Celltrion Secures the US FDA’s Approval for Avtozma IV/SC (Biosimilar, Actemra)
Shots: The US FDA has approved Avtozma IV/SC (biosimilar, Actemra) to treat rheuma...
Shots: The US FDA has approved Avtozma IV/SC (biosimilar, Actemra) to treat rheuma...
Shots: Dr. Reddy’s & Henlius have entered into a license agreement to de...
Shots: Samsung Bioepis and Teva have signed a development and commerci...
Shots: The EMA has accepted the MAA of BAT2506, a biosimilar version of Simponi (g...
Shots: The US FDA has approved Avtozma (biosimilar, Actemra) for treating diseases...
Shots: The US FDA has accepted BLA for AVT05, a biosimilar version of Simponi &...
Incisive News in 3 Shots.
Modal body text goes here.